Status:
COMPLETED
The Safety and Effectiveness of MK0476 (Montelukast) in Patients With Chronic Asthma (0476-388)
Lead Sponsor:
Organon and Co
Conditions:
Chronic Asthma
Eligibility:
All Genders
15-65 years
Phase:
PHASE1
Brief Summary
This study will test the safety and effectiveness of a range of doses of MK0476 (montelukast) compared to placebo on improved lung function in patients with chronic asthma.
Eligibility Criteria
Inclusion
- A person is 15 to 65 years of age. A person has had chronic asthma for at least one year
Exclusion
- A person is a smoker or has smoked more that a pack a day for more than 10 years before stopping
- A person has other lung disorders such as COPD (chronic obstructive pulmonary disorder)
Key Trial Info
Start Date :
July 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2008
Estimated Enrollment :
68 Patients enrolled
Trial Details
Trial ID
NCT00739297
Start Date
July 1 2008
End Date
December 1 2008
Last Update
May 9 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.